BioNap
Long/short equity

Plenty Of Upside Remains In ULURU, Inc.

ULURU, Inc. (OTCQB:ULUR) shares have been on a tear over the past few months as investors discovering the story and starting to appreciate the cheap valuation and up-side potential in the stock. Below we provide an analysis of the company's recent financial results. We also provide a quick refresh of the investment thesis for new investors to the ULURU name, and conclude with our belief that the stock is are worth $2.50 per share.

…Scale-Up Issues Impact Revenue Ramp…

On March 31, 2014, ULURU, Inc. reported financial results for the fourth quarter and full year ending December 31, 2013. Revenues for the fourth quarter totaled $129k, comprised of $94k in products sales, $15k in licensing fees, and $20k

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details